Dianthus Therapeutics
The Executive Director, Head of Bioanalytical Sciences leads the company's bioanalytical strategy and execution across research, translational, and clinical development. This senior scientific authority role serves as a key partner to program teams and senior leadership while ensuring assay readiness and data quality. The position involves building a scalable function and managing resources across internal teams, CROs, and external collaborators.
Dianthus Therapeutics is a biotechnology company focused on developing next‑generation antibody therapeutics that target the complement system to address diseases with high unmet medical need. The company engineers selective, potent complement‑modulating antibodies with the goal of improving safety and efficacy over existing therapies. Dianthus advances novel antibody candidates toward clinical development and is committed to translating complement biology into meaningful treatments for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dianthus Therapeutics.
Dianthus Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Truist Financial Forecasts Strong Price Appreciation for Dianthus Therapeutics (NASDAQ:DNTH) Stock
2 hours ago
Biomarker & Bioanalytical Development Lead
Borealisbio
Associate Director, Bioanalytical Sciences
Alector
Associate Director, Bioanalytical Sciences & Biomarkers
Arbor Biotechnologies
Scientist, Bioanalytical Sciences
lifelancer
Associate Director, Bioanalytical Sciences
kaileratherapeutics
Principal Scientist - Immunogenicity Bioanalytical Sciences
Amgen